Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VRCA Verrica Pharmaceuticals Inc.

盘后交易 03-30 19:19:57 EDT

4.76

+0.38

+8.68%

盘后4.52

-0.24-5.04%

16:26 EDT

最高4.87	最低4.43	成交量6.87万
今开4.43	昨收4.38	日振幅10.02%
总市值8,177万	流通市值3,226万	总股本1,718万
成交额32.48万	换手率1.01%	流通股本677.74万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VRCA","market":"US","secType":"STK","nameCN":"Verrica Pharmaceuticals Inc.","latestPrice":4.76,"timestamp":1774900800000,"preClose":4.38,"halted":0,"volume":68733,"hourTrading":{"tag":"盘后","latestPrice":4.52,"preClose":4.76,"latestTime":"16:26 EDT","volume":233,"amount":1087.7200512,"timestamp":1774902360546,"change":-0.24,"changeRate":-0.05042,"amplitude":0.05042},"delay":0,"changeRate":0.08675799086757989,"floatShares":6777400,"shares":17178800,"eps":-1.68,"marketStatus":"盘后交易","change":0.38,"latestTime":"03-30 19:19:57 EDT","open":4.43,"high":4.8688,"low":4.43,"amount":324801.3939,"amplitude":0.100183,"askPrice":6.51,"askSize":100,"bidPrice":4.46,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.68,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774915200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1529035200000,"exchange":"NASDAQ","adjPreClose":4.38,"postHourTrading":{"tag":"盘后","latestPrice":4.52,"preClose":4.76,"latestTime":"16:26 EDT","volume":233,"amount":1087.7200512,"timestamp":1774902360546,"change":-0.24,"changeRate":-0.05042,"amplitude":0.05042},"volumeRatio":0.67566,"impliedVol":0.3196,"impliedVolPercentile":0.8272},"requestUrl":"/m/hq/s/VRCA","defaultTab":"news","newsList":[{"id":"2618390891","title":"Verrica制药股价重挫14.05% 市值跌1154.74万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618390891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618390891?lang=zh_cn&edition=full","pubTime":"2026-03-11 21:31","pubTimestamp":1773235862,"startTime":"0","endTime":"0","summary":"北京时间2026年03月11日21时31分，Verrica制药股票出现异动，股价急速下跌14.05%。截至发稿，该股报5.14美元/股，成交量2.1518万股，换手率0.13%，振幅1.51%。最近的财报数据显示，该股实现营业收入14.34百万美元，净利润-274000.00美元，每股收益-0.03美元，毛利13.24百万美元，市盈率-1.79倍。Verrica制药股票所在的生物技术行业中，整体跌幅为0.08%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311213102a46169a9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260311213102a46169a9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"1190033327","title":"Verrica制药公司：推进VP-315于2026年进入基底细胞癌三期临床试验计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1190033327","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190033327?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:16","pubTimestamp":1773231367,"startTime":"0","endTime":"0","summary":"Verrica制药公司正积极推进其候选药物VP-315的开发进程。该药物针对基底细胞癌的治疗，预计将在2026年进入关键的第三阶段临床试验计划。这一进展标志着公司在皮肤病治疗领域的重要步伐。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1114940124","title":"Verrica Pharmaceuticals计划与Torii制药于2026年中启动Ycanth在美国和日本的第二阶段3期研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1114940124","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114940124?lang=zh_cn&edition=full","pubTime":"2026-03-11 20:14","pubTimestamp":1773231253,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（简称：Verrica）宣布，公司预计将于2026年中期与Torii Pharmaceutical合作，在美国和日本启动其候选药物Ycanth的第二项3期临床试验。这一进展标志着Ycanth在治疗领域的开发进程迈出重要一步，为后续市场拓展奠定基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1184224158","title":"Verrica Pharmaceuticals Inc. 将于2026年3月11日公布2025年第四季度及全年财务业绩并发布公司最新动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1184224158","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184224158?lang=zh_cn&edition=full","pubTime":"2026-03-05 21:04","pubTimestamp":1772715849,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. 宣布，计划于2026年3月11日发布其2025年第四季度及全年的财务业绩报告。届时，公司管理层还将提供最新的业务进展和公司战略更新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1135604881","title":"Verrica制药宣布合作伙伴鸟居药品在日本推出Ycanth®用于传染性软疣治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1135604881","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135604881?lang=zh_cn&edition=full","pubTime":"2026-02-09 21:05","pubTimestamp":1770642317,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.（简称：Verrica制药）宣布，其合作伙伴鸟居药品株式会社已在日本市场正式推出Ycanth®（cantharidin，0.7% topical solution），该产品获批用于治疗传染性软疣。这一重要进展标志着Verrica制药的核心产品成功进入全球主要医药市场之一，将为日本患者提供一种全新的非侵入性治疗选择。Ycanth®是首个且目前唯一经美国FDA批准、采用专有技术平台开发的传染性软疣局部治疗药物，其活性成分斑蝥素通过靶向病变部位实现有效治疗。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2608095458","title":"Verrica制药盘中异动 股价大跌5.50%报7.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608095458","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608095458?lang=zh_cn&edition=full","pubTime":"2026-02-04 01:17","pubTimestamp":1770139039,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日01时17分，Verrica制药股票出现波动，股价急速跳水5.50%。截至发稿，该股报7.04美元/股，成交量3.7485万股，换手率0.23%，振幅4.83%。机构评级方面，在所有5家参与评级的机构中，80%的券商给予买入建议，20%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体跌幅为0.10%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401171997a4b71f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026020401171997a4b71f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1185762151","title":"Verrica制药启动Ycanth®（VP-102）治疗寻常疣三期临床项目 首位患者完成给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1185762151","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185762151?lang=zh_cn&edition=full","pubTime":"2026-01-07 21:04","pubTimestamp":1767791059,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. (VRCA) 宣布，其针对寻常疣治疗的三期临床试验项目已完成首位患者给药。该研究旨在评估候选药物Ycanth®（VP-102）的疗效与安全性。\n作为一款创新疗法，Ycanth®若通过临床验证，有望为常见皮肤疾病患者提供新的治疗选择。此次三期项目的推进标志着该药物研发进入关键阶段。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2601281334","title":"Verrica制药盘中异动 股价大涨5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601281334","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601281334?lang=zh_cn&edition=full","pubTime":"2026-01-05 23:17","pubTimestamp":1767626258,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日23时17分，Verrica制药股票出现异动，股价急速拉升5.40%。截至发稿，该股报8.75美元/股，成交量9313股，换手率0.06%，振幅6.85%。Verrica制药股票所在的生物技术行业中，整体跌幅为1.80%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105231738a49f885e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105231738a49f885e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2593942021","title":"Verrica制药盘中异动 早盘股价大涨6.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593942021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593942021?lang=zh_cn&edition=full","pubTime":"2025-12-23 22:54","pubTimestamp":1766501655,"startTime":"0","endTime":"0","summary":"北京时间2025年12月23日22时54分，Verrica制药股票出现波动，股价急速拉升6.19%。截至发稿，该股报8.40美元/股，成交量3.877万股，换手率0.24%，振幅5.56%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.05%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223225415a6c67014&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251223225415a6c67014&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2588502160","title":"Verrica制药盘中异动 早盘股价大跌5.70%报7.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588502160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588502160?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:21","pubTimestamp":1764692513,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日00时21分，Verrica制药股票出现异动，股价大幅下跌5.70%。截至发稿，该股报7.12美元/股，成交量8.6352万股，换手率0.91%，振幅4.24%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体跌幅为0.15%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203002153a4c87566&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203002153a4c87566&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1153578772","title":"Verrica Pharmaceuticals Inc. - 与机构投资者签订证券购买协议 - SEC备案","url":"https://stock-news.laohu8.com/highlight/detail?id=1153578772","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1153578772?lang=zh_cn&edition=full","pubTime":"2025-11-25 00:21","pubTimestamp":1764001286,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc. - 与机构投资者签订证券购买协议 - SEC备案","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"1109667485","title":"Verrica Pharmaceuticals 宣布5000万美元的私募融资，以偿还债务并延长现金储备","url":"https://stock-news.laohu8.com/highlight/detail?id=1109667485","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1109667485?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:01","pubTimestamp":1763989275,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals 宣布5000万美元的私募融资，以偿还债务并延长现金储备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"1142780870","title":"Verrica Pharmaceuticals在第40届癌症免疫治疗学会年会上发布Vp-315的二期临床试验新数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1142780870","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142780870?lang=zh_cn&edition=full","pubTime":"2025-11-10 21:06","pubTimestamp":1762779988,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals在第40届癌症免疫治疗学会年会上发布Vp-315的二期临床试验新数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2581274687","title":"Verrica制药盘中异动 早盘大幅下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581274687","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581274687?lang=zh_cn&edition=full","pubTime":"2025-11-04 22:40","pubTimestamp":1762267201,"startTime":"0","endTime":"0","summary":"北京时间2025年11月04日22时40分，Verrica制药股票出现波动，股价大幅跳水5.34%。截至发稿，该股报3.37美元/股，成交量1.2852万股，换手率0.14%，振幅4.76%。Verrica制药股票所在的生物技术行业中，整体跌幅为0.69%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104224002a6e0b9e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251104224002a6e0b9e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TERN","BK4007","VRCA"],"gpt_icon":0},{"id":"1190273267","title":"Verrica Pharmaceuticals Inc.宣布合作伙伴Torii Pharmaceutical的Ycanth®(to-208)在日本获批用于治疗传染性软疣","url":"https://stock-news.laohu8.com/highlight/detail?id=1190273267","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190273267?lang=zh_cn&edition=full","pubTime":"2025-09-19 20:00","pubTimestamp":1758283214,"startTime":"0","endTime":"0","summary":"Verrica Pharmaceuticals Inc.宣布其开发合作伙伴Torii Pharmaceutical的Ycanth®(to-208)药物在日本获得批准，用于治疗传染性软疣。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2568044773","title":"Verrica制药盘中异动 早盘股价大涨7.94%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568044773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568044773?lang=zh_cn&edition=full","pubTime":"2025-09-17 21:33","pubTimestamp":1758115990,"startTime":"0","endTime":"0","summary":"北京时间2025年09月17日21时33分，Verrica制药股票出现异动，股价急速拉升7.94%。截至发稿，该股报4.76美元/股，成交量847股，换手率0.01%，振幅0.00%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.30%。Verrica制药公司简介：Verrica Pharmaceuticals Inc是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的益处的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917213310a72672f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250917213310a72672f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2518227291","title":"Verrica制药盘中异动 临近午盘快速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227291","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518227291?lang=zh_cn&edition=full","pubTime":"2025-03-10 23:46","pubTimestamp":1741621565,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日23时46分，Verrica制药股票出现异动，股价急速上涨5.30%。截至发稿，该股报0.640美元/股，成交量13.9209万股，换手率0.15%，振幅7.71%。Verrica制药股票所在的生物技术行业中，整体涨幅为0.14%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031023460696405344&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","BK4007"],"gpt_icon":0},{"id":"2516677013","title":"Verrica制药盘中异动 早盘股价大跌7.44%报0.593美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677013","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516677013?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:46","pubTimestamp":1741099583,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时46分，Verrica制药股票出现波动，股价快速下跌7.44%。截至发稿，该股报0.593美元/股，成交量9.0819万股，换手率0.10%，振幅11.19%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.36%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224623989bb086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0},{"id":"2514378122","title":"Verrica制药盘中异动 早盘股价大涨5.07%报0.620美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378122?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:31","pubTimestamp":1740753116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时31分，Verrica制药股票出现异动，股价大幅上涨5.07%。截至发稿，该股报0.620美元/股，成交量7287股，换手率0.01%，振幅0.00%。机构评级方面，在所有4家参与评级的机构中，50%的券商给予买入建议，50%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.02%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223156989679bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VRCA","VRPX","BK4007"],"gpt_icon":0},{"id":"2514380226","title":"Verrica制药盘中异动 股价大跌6.70%报0.662美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514380226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514380226?lang=zh_cn&edition=full","pubTime":"2025-02-28 01:01","pubTimestamp":1740675685,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日01时01分，Verrica制药股票出现异动，股价急速下跌6.70%。截至发稿，该股报0.662美元/股，成交量12.3952万股，换手率0.14%，振幅6.39%。机构评级方面，在所有5家参与评级的机构中，40%的券商给予买入建议，60%的券商给予持有建议，无券商给予卖出建议。Verrica制药股票所在的生物技术行业中，整体涨幅为0.40%。Verrica制药公司简介：Verrica Pharmaceuticals Inc 是一家皮肤科治疗公司，致力于为皮肤病患者提供有意义的有益的新型治疗方法的开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228010126abdf91c6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","VRCA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.verrica.com","stockEarnings":[{"period":"1week","weight":-0.1963},{"period":"1month","weight":-0.2136},{"period":"3month","weight":-0.4632},{"period":"6month","weight":0.0478},{"period":"1year","weight":0.0011},{"period":"ytd","weight":-0.4729}],"compareEarnings":[{"period":"1week","weight":-0.0223},{"period":"1month","weight":-0.0852},{"period":"3month","weight":-0.0814},{"period":"6month","weight":-0.0419},{"period":"1year","weight":0.1182},{"period":"ytd","weight":-0.0701}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verrica Pharmaceuticals Inc.于2013年7月3日根据特拉华州法律注册成立。该公司是一家开发和商业化用于皮肤病（包括皮肤癌）的临床施用治疗药物的公司。其商业化产品YCANTH已获批用于治疗传染性软疣，研发管线中还包括针对寻常疣和基底细胞癌的候选药物。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":0.064974},{"month":2,"riseRate":0.5,"avgChangeRate":0.04305},{"month":3,"riseRate":0.25,"avgChangeRate":-0.075925},{"month":4,"riseRate":0.428571,"avgChangeRate":-0.016247},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.140402},{"month":6,"riseRate":0.571429,"avgChangeRate":0.076173},{"month":7,"riseRate":0.5,"avgChangeRate":0.012098},{"month":8,"riseRate":0.5,"avgChangeRate":-0.04466},{"month":9,"riseRate":0.25,"avgChangeRate":-0.080364},{"month":10,"riseRate":0.125,"avgChangeRate":-0.088008},{"month":11,"riseRate":0.5,"avgChangeRate":0.227615},{"month":12,"riseRate":0.375,"avgChangeRate":0.021484}],"exchange":"NASDAQ","name":"Verrica Pharmaceuticals Inc.","nameEN":"Verrica Pharmaceuticals Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verrica Pharmaceuticals Inc.,VRCA,Verrica Pharmaceuticals Inc.股票,Verrica Pharmaceuticals Inc.股票老虎,Verrica Pharmaceuticals Inc.股票老虎国际,Verrica Pharmaceuticals Inc.行情,Verrica Pharmaceuticals Inc.股票行情,Verrica Pharmaceuticals Inc.股价,Verrica Pharmaceuticals Inc.股市,Verrica Pharmaceuticals Inc.股票价格,Verrica Pharmaceuticals Inc.股票交易,Verrica Pharmaceuticals Inc.股票购买,Verrica Pharmaceuticals Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verrica Pharmaceuticals Inc.(VRCA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verrica Pharmaceuticals Inc.(VRCA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}